Live feed
Filing
SC 13G/A
SC 13G/A0000935836-22-000126·CTI BIOPHARMA CORP
Schedule 13G ownership disclosure
CTI BIOPHARMA CORP
Security class unavailable · CUSIP: 12648L601
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,754,935
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-22-000126
- Form type
- SC 13G/A
- Filer
- CTI BIOPHARMA CORP
- CIK
- CIK 891293
- Filed
- Feb 14, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership